LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release

Author(s):  Bogner Robin H, Szwejkowski Jessica, Houston Alana

Issue:  Sep/Oct 2001 - Bioidentical Hormone Replacement Therapy
View All Articles in Issue

Abstract:  Morphine sulfate is often used to treat severe pain. Pharmacists have been requested to compound morphine sulfate sustained- release capsules in dosages that are not available commercially. However, there has been considerable controversy about the advisability of that practice. This study determined the release of six formulations of 300 mg morphine sulfate sustained- release capsules by means of a United States Pharmacopeia (USP) type III dissolution apparatus. The formulation suggested by a reputable compounding consulting company released almost half the morphine in the first hour of a timerelease test and did not adequately sustain the release of the remainder. With increases in the level of hydroxypropyl methylcellulose (Methocel), the release was prolonged and the amount of drug released during the first hour was reduced. One formulation of encapsulated compressed pellets showed that the release could be sustained significantly beyond that of the original formulation. In addition, the increased agitation that occurs in the gastrointestinal tract when the medication is taken after a meal reduced the period of sustained release and slightly increased the amount of morphine released during the first hour after administration. In conclusion, the original formula of morphine sulfate sustained-release capsules (Formula A) is probably not adequate for most applications. The formulations with a greater percentage of Methocel are preferred. In addition, the pelleted formulation was superior; however, it may not be feasible to use this labor-intensive approach to compound capsules.

Related Keywords: Morphine sulfate, slow-release capsules, effect of formulation on

Related Categories: PAIN MANAGEMENT, PEER-REVIEWED

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Bogner Robin H, Szwejkowski Jessica, Houston Alana Sep/Oct 2001 401-405 Buy
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules Webster Kathy D, Al-Achi Antoine, Greenwood Robert Sep/Oct 1999 409-411 Buy
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride Glowiak Dana L, Green Julie L, Bowman Bill J Mar/Apr 2005 157-164 Buy
Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix Timmons Evelyn D, Timmons Steven P Sep/Oct 2002 378 Buy
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Zur Eyal Jan/Feb 2013 10-22 Buy
Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Radojkovic Branko, Milic Jela, Calija Bojan Sep/Oct 2012 434-437 Buy
Morphine Sulfate Slow-Release Suppositories Allen Loyd V Jr Jan/Feb 1997 32-33 Buy
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes Xu Quanyun A, Trissel Lawrence A, Pham Lien Jan/Feb 2002 66-69 Buy
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes Trissel Lawrence A, Xu Quanyun A, Pham Lien Jan/Feb 2002 70-73 Buy
Basics of Compounding: Special Capsules Allen Loyd V Jr May/Jun 2016 209-214 Buy